Current Opinion in Pharmacology

Top Research Topics at Current Opinion in Pharmacology?

Current Opinion in Pharmacology mainly deals with areas of study such as Immunology, Pharmacology, Internal medicine, Neuroscience and Receptor. The work on Immunology addressed in it expands to the thematically related Disease. In the journal, Bioinformatics and Intensive care medicine are investigated in conjunction with one another to address concerns in Disease research.

Current Opinion in Pharmacology features studies on Pharmacology, including topics such as Drug. The Internal medicine works featured in it incorporate elements from Gastroenterology, Endocrinology, Oncology and Cardiology. The in-depth study on Neuroscience also explores topics in the intersecting field of Glutamate receptor.

Current Opinion in Pharmacology investigates Receptor research which frequently intersects with Cell biology. The Cell biology works, particularly on Signal transduction are tackled in it.

• Immunology (17.45%)
• Pharmacology (17.37%)
• Internal medicine (16.81%)

What are the most cited papers published in the journal?

• Dissecting components of reward: 'liking', 'wanting', and learning. (1251 citations)
• Vitamin D: modulator of the immune system. (793 citations)
• Antibacterial peptides for therapeutic use: obstacles and realistic outlook. (781 citations)

Research areas of the most cited articles at Current Opinion in Pharmacology:

Pharmacology, Neuroscience, Receptor, Internal medicine and Immunology are the main subjects of interest in the published articles. The most cited articles hold forums on Receptor that merge themes from other disciplines such as Signal transduction and Cell biology. The journal publications explore research in Immunology alongside concepts in Cancer and other areas of study in Cancer research.

What topics the last edition of the journal is best known for?

• Internal medicine
• Gene
• Disease

The previous edition focused in particular on these issues:

The journal primarily focuses on research topics in Disease, Neuroscience, Bioinformatics, Internal medicine and Intensive care medicine. It mainly concentrates on Disease but also investigates its connection with concepts in disciplines such as

• Pathogenesis together with Cell biology,
• Virology which intersects with area such as Monoclonal antibody.. Current Opinion in Pharmacology explores topics in Neuroscience which can be helpful for research in disciplines like Glutamate receptor, Receptor and Synaptic plasticity.

The presented research on Bioinformatics deals specifically with Adipose tissue but it also addresses topics in Immune system. Current Opinion in Pharmacology explores studies in Immune system as part of the wider topic of Immunology. The research on Internal medicine tackled can also make contributions to studies in the areas of Diabetes mellitus, Endocrinology, Oncology, MEDLINE and Cardiology.

The most cited articles from the last journal are:

• Prospects for COPD treatment (9 citations)
• Chronotherapy of cardiac and vascular disease: timing medications to circadian rhythms to optimize treatment effects and outcomes. (6 citations)
• Circadian control of human cardiovascular function. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Current Opinion in Pharmacology (based on the number of publications) are:

• Clive P. Page (10 papers) published 1 paper at the last edition,
• Dimitris Tousoulis (8 papers) absent at the last edition,
• Francesco Di Virgilio (7 papers) published 1 paper at the last edition,
• Giacinto Bagetta (7 papers) published 1 paper at the last edition,
• Mario Cazzola (7 papers) published 2 papers at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Current Opinion in Pharmacology (based on the number of publications) are:

• National Institutes of Health (50 papers) published 1 paper at the last edition,
• GlaxoSmithKline (43 papers) absent at the last edition,
• Imperial College London (40 papers) absent at the last edition,
• French Institute of Health and Medical Research (39 papers) absent at the last edition,
• King's College London (32 papers) published 1 paper at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.92% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 4.31% were posted by at least one author from the top 10 institutions publishing in the journal. Another 13.79% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 12.07% of all publications and 69.83% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Pharmacology

For individuals interested in the field of pharmacology, numerous career paths are available. From research and development to regulatory affairs, the spectrum of opportunities in pharmacology spans a wide range. One particular career path gaining rise in recent years due to the interdisciplinary nature of pharmacology is that of a Nurse Practitioner with a specialty in pharmacology. By becoming a Nurse Practitioner with a specialization in pharmacology, one can play a pivotal role in patient care, providing both medical and pharmacological remedies. Their knowledge extends from administering and prescribing medications to understanding the effects and interactions these medications can have in the body. This advanced role in nursing requires specialized training beyond general nursing education. Usually, it requires a Master's Degree in Nursing and additional certification in pharmacology. For more specific details on the pathway to becoming a nurse practitioner specialized in pharmacology, you can visit our comprehensive guide on nurse practitioner program requirements in Colorado. By giving due consideration to such career opportunities in pharmacology, one can use the knowledge of research topics as discussed in publications like 'Current Opinion in Pharmacology' to stay ahead of the curb and maintain a future-forward approach to their career in healthcare and pharmacology.